Exocrine pancreas function is impaired in adult relatives of patients with type 1 diabetes

Acta Diabetol. 2022 Apr;59(4):473-479. doi: 10.1007/s00592-021-01819-2. Epub 2021 Nov 15.

Abstract

Aims: Alterations of the exocrine pancreas have been reported in type 1 diabetes, but their contribution to the pathogenesis of the disease is poorly understood. Here, we investigated markers of exocrine pancreas dysfunction in individuals at-risk of developing type 1 diabetes.

Methods: Serum P-amylase and lipase levels were assessed in samples obtained from healthy controls, patients with new onset type 1 diabetes, relatives participating to the TrialNet Pathway to Prevention who were, at blood collection, autoantibody negative or positive for a single autoantibody (low-risk individuals), and positive for multiple autoantibodies (high-risk individuals). Linear mixed models were adopted to estimate variation of pancreatic enzymes among the groups and to evaluate the influence of high-risk HLA genotypes and residual beta cell function on exocrine pancreas function.

Results: In adults, but not children, reduced levels of P-amylase and lipase were shown in at-risk individuals, including (for P-amylase levels only) those at low-risk, and in T1Dnew. Furthermore, while high-risk HLA genotypes negatively affected P-amylase levels in autoantibody negative adult individuals, fasting C-peptide levels did not correlate with pancreatic enzyme levels.

Conclusions: Exocrine pancreas dysfunction precedes the onset of type 1 diabetes in adult at-risk individuals and may be unrelated to fasting C-peptide levels.

Keywords: Exocrine pancreas; P-amylase; Pre-symptomatic T1D; Type 1 diabetes.

MeSH terms

  • Adult
  • Amylases / metabolism
  • Autoantibodies / metabolism
  • Biomarkers / metabolism
  • Diabetes Mellitus, Type 1*
  • Humans
  • Pancreas / metabolism
  • Pancreas, Exocrine* / metabolism

Substances

  • Autoantibodies
  • Biomarkers
  • Amylases